Kazi, D. S., Penko, J., Coxson, P. G., Moran, A. E., Ollendorf, D. A., Tice, J. A., & Bibbins-Domingo, K. (2017). Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial. JAMA.

Kazi, Dhruv S., Joanne Penko, Pamela G. Coxson, Andrew E. Moran, Daniel A. Ollendorf, Jeffrey A. Tice, and Kirsten Bibbins-Domingo. "Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based On the Results of the FOURIER Trial." JAMA 2017.

Kazi, Dhruv S., et al. "Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based On the Results of the FOURIER Trial." JAMA 2017.